Daiwa Securities Group’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9K | Hold |
581
| – | – | ﹤0.01% | 1123 |
|
2025
Q1 | $10K | Buy |
581
+97
| +20% | +$1.67K | ﹤0.01% | 1096 |
|
2024
Q4 | $12K | Sell |
484
-53
| -10% | -$1.31K | ﹤0.01% | 1109 |
|
2024
Q3 | $15K | Hold |
537
| – | – | ﹤0.01% | 1114 |
|
2024
Q2 | $14K | Hold |
537
| – | – | ﹤0.01% | 1142 |
|
2024
Q1 | $17K | Sell |
537
-55
| -9% | -$1.74K | ﹤0.01% | 1136 |
|
2023
Q4 | $25K | Buy |
592
+72
| +14% | +$3.04K | ﹤0.01% | 1107 |
|
2023
Q3 | $20K | Hold |
520
| – | – | ﹤0.01% | 1092 |
|
2023
Q2 | $10K | Hold |
520
| – | – | ﹤0.01% | 1130 |
|
2023
Q1 | $8K | Hold |
520
| – | – | ﹤0.01% | 1113 |
|
2022
Q4 | $9K | Buy |
520
+126
| +32% | +$2.18K | ﹤0.01% | 1112 |
|
2022
Q3 | $2K | Hold |
394
| – | – | ﹤0.01% | 1223 |
|
2022
Q2 | $2K | Hold |
394
| – | – | ﹤0.01% | 1229 |
|
2022
Q1 | $2K | Hold |
394
| – | – | ﹤0.01% | 1246 |
|
2021
Q4 | $3K | Hold |
394
| – | – | ﹤0.01% | 1236 |
|
2021
Q3 | $3K | Buy |
394
+210
| +114% | +$1.6K | ﹤0.01% | 1208 |
|
2021
Q2 | $2K | Hold |
184
| – | – | ﹤0.01% | 1135 |
|
2021
Q1 | $3K | Hold |
184
| – | – | ﹤0.01% | 1106 |
|
2020
Q4 | $8K | Buy |
+184
| New | +$8K | ﹤0.01% | 1026 |
|